Unequal Access to New Myasthenia Gravis Therapies Across Europe Highlights Healthcare Disparities
By
Euractiv
Summary
This article examines the growing gap between medical innovation and patient access in the treatment of generalised myasthenia gravis (gMG) across Europe. While new therapies are transforming expectations for gMG care, unequal access persists across countries and communities. The piece highlights the need for better diagnosis, specialist referral pathways, and more consistent access to care to improve patient outcomes while supporting health system resilience, workforce participation, and economic sustainability.
Source
Key quotes
· 3 pulledGeneralised myasthenia gravis (gMG) may be a rare disease, but the questions it raises for Europe's healthcare systems are increasingly urgent: how quickly can medical innovation reach patients, and how can access be delivered evenly across countries and communities?
For people living with gMG the stakes are high.
While there is still no cure, advances in treatment are transforming expectations for
You might also wanna read
Experts at HLTH Europe discuss using AI and better data to close the women's health gap
The article reports on discussions at HLTH Europe in Amsterdam about closing the women's health gap through AI and better data. Experts high
European patients turn to AI chatbots for medical guidance amid healthcare gaps
Patients in Europe, particularly those with rare or complex conditions, are increasingly turning to AI chatbots like ChatGPT for medical adv
Personal Reflection on Using Proprietary Medical Devices for Diabetes Management
The article discusses the author's personal experience with diabetes and their difficult choice to use a proprietary continuous glucose moni
UK and Ireland Audit Reveals Gender Disparity in Advanced Heart Failure Referrals
A national audit of advanced heart failure referrals across the UK and Ireland reveals significant gender disparity, with women accounting f
AGA Updates Clinical Guidance for Obesity and Weight Management Treatment Options
The American Gastroenterological Association (AGA) has updated its POWER (Practice Guide on Obesity and Weight Management, Education, and Re
Considerations in Medicine relaunches with BMJ Group to prioritize methodological rigor over novelty in clinical research
This article introduces the relaunch of Considerations in Medicine with BMJ Group in August 2025. The journal aims to address the imbalance

Comments
Sign in to join the conversation.
No comments yet. Be the first.